Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-634-6 | CAS number: 61167-58-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 Feb - 25 Jul 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- adopted Jul 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of assay:
- other: in vitro gene mutation study in mammalian cells
Test material
- Reference substance name:
- 2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate
- EC Number:
- 262-634-6
- EC Name:
- 2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate
- Cas Number:
- 61167-58-6
- Molecular formula:
- C26H34O3
- IUPAC Name:
- 2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenyl prop-2-enoate
Constituent 1
Method
- Target gene:
- HPRT locus
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Laboratory for Mutagenicity Testing, Technical University, Darmstadt, Germany
- Suitability of cells: The V79 cell line has been used successfully in in vitro experiments for many years.
- Methods for maintenance in cell culture: Thawed stock cultures were propagated at 37 °C with 1.5% carbon dioxide in 76 cm² plastic flasks and sub-cultured once or twice weekly.
- Modal number of chromosomes: 22
- Normal cell cycle time: 12 - 16 h
MEDIA USED
- Type and identity of media: MEM (minimal essential medium) containing Hank’s salts supplemented with 10% foetal bovine serum (FBS), neomycin (5 μg/mL) and amphotericin B (1%).
- Properly maintained: Yes
- Periodically checked for Mycoplasma contamination: Yes
- Periodically checked for karyotype stability: Yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- co-factor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/β-naphthoflavone
- Test concentrations with justification for top dose:
- Pre-experiment for toxicity:
With and without S9 mix: 7.8, 15.6, 31.3, 62.5, 125, 250, 500 and 1000 µg/mL (4 h)
The following concentrations were selected in the main experiments for the mutagenicity testing:
Experiment I
Without S9 mix: 0.98, 1.96, 3.91, 7.83 µg/mL (4 h)
With S9 mix: 0.98, 1.96, 3.91, 7.83, 15.65 µg/mL (4 h)
Experiment II (repeat experiment)
With S9 mix: 0.98, 1.96, 3.91, 7.83, 15.65 µg/mL (4 h)
Experiment III
Without S9 mix: 0.98, 1.96, 3.91, 7.83 µg/mL (4 h)
With S9 mix: 0.98, 1.96, 3.91, 7.83, 15.65 µg/mL (4h) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent: The solvent was chosen to its solubility properties and its relative non-toxicity to the cell cultures on request of the sponsor.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
- Cell density at seeding: Approximately 1.2 x 10E07 cells/mL
DURATION
- Exposure duration: 4 h with and without metabolic activation
- Expression time (cells in growth medium): Approximately 7 days
- Selection time (if incubation with a selection agent): About 8 days
SELECTION AGENT (mutation assays): 11 µg/mL 6-thioguanine
STAIN: 10% methylene blue in 0.01% KOH solution
NUMBER OF REPLICATIONS: Duplicates each in 3 independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item is classified as clearly positive if it induces a significant and concentration-related increase of the mutant frequency exceeding the historical solvent control range.
When a test item cannot be classified as clearly positive, additional experiments will be performed to establish the biological relevance of the result.
A test item producing a reproducible concentration-related increase of the mutant frequency above the historical solvent control range is considered to be mutagenic in this system.
A test item producing no reproducible concentration-related increase of the mutant frequency above the historical solvent control range is considered to be non-mutagenic in this system. - Statistics:
- A linear regression was performed using a validated test script of "R", a language and environment for statistical computing and graphics (p<0.05), to assess a possible dose dependent increase of mutant frequencies. The number of mutant colonies obtained for the groups treated with the test item were compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05.
A t-Test was performed using a validated test script of “R”, a language and environment for statistical computing and graphics, whenever the mutation frequency at a test point exceeded the 95% confidence interval. Again a t-test is judged as significant if the p-value (probability value) is below 0.05.
However, both, biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Experiment I: ≥ 3.9 µg/mL without metabolic activation; Experiment III: ≥ 3.9 µg/mL with and without metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: The pH-value was determined in culture medium of the solvent control and at the maximum concentration of the pre-experiment without metabolic activation and was 7.51 and 7.52, respectively.
- Effects of osmolality: The osmolarity [mOsm] was determined in culture medium of the solvent control and at the maximum concentration of the pre-experiment without metabolic activation and was 399 and 381, respectively.
- Precipitation: Precipitation was observed macroscopically and microscopically at the end of treatment (4 h) prior to the removal of the test substance at 15.6 μg/mL in the absence and presence of metabolic activation.
RANGE-FINDING/SCREENING STUDIES: A pre-test was performed in order to determine the toxicity of the test substance. The pre-experiment was performed in the presence and absence (4 h treatment) of metabolic activation. The test substance was tested at concentrations between 7.8 μg/mL and 1000.0 μg/mL. The highest concentration of the pre-experiment was chosen due to precipitation observed in the pre-test on solubility. Relevant cytotoxic effects indicated by a relative cloning efficiency of 50% or below were observed at 125.0 μg/mL in the presence and absence of metabolic activation following 4 hours treatment.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: The positive control values were within the range of the historical control data (please refer to Table 1 under "any other information on material and methods incl. tables").
- Negative (solvent/vehicle) historical control data: The negative and solvent control values were within the range of the historical control data (please refer to Table 1 under "any other information on material and methods incl. tables").
A linear regression analysis (least squares) was performed to assess a possible dose dependent increase of mutant frequencies. No significant dose dependent trend of the mutation frequency indicated by a probability value of <0.05 was determined in any of the main experiments.
In experiment I, the 95% confidence interval was exceeded at 3.91 μg/mL in culture II in the absence of metabolic activation (please refer to Table 2 under "any other information on results incl. tables"). In experiment II, the 95% confidence interval was very slightly exceeded at 7.83 μg/mL and 15.65 μg/mL in culture I (please refer to Table 3 under "any other information on results incl. tables").
A t-test evaluating the data of both parallel cultures at the data points exceeding the 95% confidence interval showed only a significant response in experiment I at 3.91 μg/mL without metabolic activation. The other data points exceeding the 95% confidence interval at 7.83 μg/mL and 15.65 μg/mL in experiment II showed no significant response in a t-test. Since the significant difference was only detected at an intermediate concentration and no dose dependent trend was found no biological relvance can be stated for this effect.
Any other information on results incl. tables
Table 1: Toxicity data
Concentration [µg/mL] | Cloning efficiency [%] | |
- S9 | + S9 | |
0 (DMSO) | 100 | 100 |
7.8 | 101.3 | 90.6 |
15.6 P | 94.4 | 91.0 |
31.3 P | 80.0 | 80.3 |
62.5 P | 61.6 | 56.7 |
125 P | 34.4 | 28.8 |
250 P | 20.6 | 17.0 |
500 P | 13.3 | 9.0 |
1000 P | 47.0 | 19.6 |
Table 2: Summary of Experiment I (4 h, without metabolic activation)
Concentration [µg/mL] | Cloning efficiency [%] Culture I |
Mutation colonies per 10E06 cells Culture I |
Cloning efficiency [%] Culture II |
Mutation colonies per 10E06 cells Culture II |
95% confidence intervall |
Medium | 154.1 | 21.1 | 76.2 | 19.6 | 1.7 - 30.2 |
DMSO | 100 | 13.4 | 100 | 11.2 | 1.7 - 30.2 |
0.98 | 80.2 | 14.5 | 81.1 | 20.6 | 1.7 - 30.2 |
1.96 | 68.9 | 29.1 | 77.5 | 21.4 | 1.7 - 30.2 |
3.91 | 24.0 | 16.1 | 28.2 | 55.6 | 1.7 - 30.2 |
7.83 | 11.1 | 16.0 | 9.8 | 19.7 | 1.7 - 30.2 |
15.65 P | 5.4 | n.r. | 5.3 | n.r. | 1.7 - 30.2 |
31.3 P | 0.7 | # | 0.0 | # | 1.7 - 30.2 |
EMS | 91.3 | 262.0 | 74.3 | 851.6 | 1.7 - 30.2 |
P: Precipitation (visible at the beginning and at the end of treatment)
# culture was not continued due to exceedingly severe cytotoxic effects
n.r.: not reported, due to unacceptable cytotoxicity
EMS: ethylmethane sulfonate
Table 3: Summary of Experiment II (4 h, with metabolic activation)
Concentration [µg/mL] | Cloning efficiency [%] Culture I |
Mutation colonies per 10E06 cells Culture I |
Cloning efficiency [%] Culture II |
Mutation colonies per 10E06 cells Culture II |
95% confidence intervall |
Medium | 114.2 | 22.5 | 77.3 | 26.6 | 2.0 – 29.4 |
DMSO | 100.0 | 17.4 | 100.0 | 29.3 | 2.0 – 29.4 |
0.98 | 104.7 | 28.4 | 88.7 | 15.1 | 2.0 – 29.4 |
1.96 | 124.6 | 16.7 | 79.5 | 18.9 | 2.0 – 29.4 |
3.91 | 111.6 | 22.5 | 72.3 | 21.1 | 2.0 – 29.4 |
7.83 | 91.1 | 29.6 | 71.3 | 26.8 | 2.0 – 29.4 |
15.65 P | 111.0 | 31.2 | 71.0 | 17.1 | 2.0 – 29.4 |
31.3 P | 102.2 | ## | 65.4 | ## | 2.0 – 29.4 |
DMBA | 93.2 | 187.8 | 57.0 | 152.3 | 2.0 – 29.4 |
P: Precipitation (visible at the beginning and at the end of treatment)
## culture was not continued to avoid analysis of too many precipitating concentrations
DMBA: 7,12-dimethylbenz(a)anthracene
Table 4: Summary of Experiment III (4 h, with and without metabolic activation)
Concentration [µg/mL] | Cloning efficiency [%] Culture I |
Mutation colonies per 10E06 cells Culture I |
Cloning efficiency [%] Culture II |
Mutation colonies per 10E06 cells Culture II |
95% confidence intervall |
without metabolic activation | |||||
Medium | 101.1 | 11.5 | 122.2 | 12.4 | 1.7 - 30.2 |
DMSO | 100.0 | 16.1 | 100.0 | 17.9 | 1.7 - 30.2 |
0.98 | 72.1 | 14.3 | 107.1 | 13.5 | 1.7 - 30.2 |
1.96 | 48.1 | 29.3 | 91.7 | 17.1 | 1.7 - 30.2 |
3.91 | 25.8 | 16.0 | 43.2 | 21.7 | 1.7 - 30.2 |
7.83 | 17.4 | 24.0 | 33.0 | 17.6 | 1.7 - 30.2 |
15.65 P | 3.6 | n.r. | 7.7 | n.r. | 1.7 - 30.2 |
31.3 P | 1.3 | # | 4.5 | # | 1.7 - 30.2 |
EMS | 81.2 | 133.6 | 108.1 | 159.4 | 1.7 - 30.2 |
with metabolic activation | |||||
Medium | 117.9 | 13.2 | 142.2 | 20.5 | 2.0 – 29.4 |
DMSO | 100.0 | 33.4 | 100.0 | 15.2 | 2.0 – 29.4 |
0.98 | 116.9 | 17.6 | 138.2 | 25.7 | 2.0 – 29.4 |
1.96 | 117.1 | 6.2 | 99.8 | 18.1 | 2.0 – 29.4 |
3.91 | 86.9 | 16.9 | 147.0 | 26.8 | 2.0 – 29.4 |
7.83 | 108.8 | 25.1 | 132.4 | 25.0 | 2.0 – 29.4 |
15.65 P | 98.5 | 25.3 | 94.7 | 19.3 | 2.0 – 29.4 |
31.3 P | 15.0 | ## | 9.1 | ## | 2.0 – 29.4 |
DMBA | 97.5 | 216.6 | 118.8 | 152.6 | 2.0 – 29.4 |
P: Precipitation (visible at the beginning and at the end of treatment)
# culture was not continued due to exceedingly severe cytotoxic effects
## culture was not continued to avoid analysis of too many precipitating concentrations
n.r.: not reported, due to unacceptable cytotoxicity
EMS: ethylmethane sulfonate
DMBA: 7,12-dimethylbenz(a)anthracene
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.